Cogent Biosciences, Inc. (COGT)

37.34 -1.00 (-2.61%) USD  |  NASDAQ  |  Feb 20, 15:58
More

Cogent Biosciences Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade